Evaluation of Platelet Responses in Transfusion-Related Acute Lung Injury (TRALI)

被引:17
|
作者
van der Laan, Eveline A. N. Zeeuw [1 ]
van der Velden, Saskia [1 ]
Porcelijn, Leendert [2 ]
Semple, John W. [3 ]
van der Schoot, C. Ellen [1 ]
Kapur, Rick [1 ]
机构
[1] Univ Amsterdam, Amsterdam UNC, Sanquin Res, Dept Expt Immunohematol,Amsterdam & Landsteiner L, Amsterdam, Netherlands
[2] Sanquin Diagnost Serv, Dept Immunohematol Diagnost, Amsterdam, Netherlands
[3] Lund Univ, Div Hematol & Transfus Med, Lund, Sweden
关键词
Transfusion-related acute lung injury; TRALI; Platelets; 34-1-2S; Lipids; Ceramide; NEUTROPHIL EXTRACELLULAR TRAPS; CELLS; CONTRIBUTES; LIGHT;
D O I
10.1016/j.tmrv.2020.08.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Platelets are versatile cells which are capable of eliciting nonhemostatic immune functions, especially under inflammatory conditions. Depending on the specific setting, platelets may be either protective or pathogenic in acute lung injury and acute respiratory distress syndrome (ARDS). Their role in transfusion-related acute lung injury (TRALI) is less well defined; however, it has been hypothesized that recipient platelets and transfused platelets both play a pathogenic role in TRALI. Overall, despite conflicting findings, it appears that recipient platelets may play a pathogenic role in antibody-mediated TRALI; however, theft contribution appears to be limited. It is imperative to first validate the involvement of recipient platelets by standardizing the animal models, methods, reagents, and readouts for lung injury and taking the animal housing environment into consideration. for the involvement of transfused platelets in TRALI, it appears that predominantly lipids such as ceramide in stored platelets are able to induce TRALI in animal models. These studies will also need to be validated, and moreover, the platelet-derived lipid-mediated mechanisms leading to TRALI will need to be investigated. (C) 2020 Elsevier Inc. All rights reserved.
引用
收藏
页码:227 / 233
页数:7
相关论文
共 50 条
  • [1] Transfusion-related acute lung injury (TRALI)
    Teague, G
    Hughes, A
    Gaylard, D
    ANAESTHESIA AND INTENSIVE CARE, 2005, 33 (01) : 124 - 127
  • [2] Transfusion-related acute lung injury (TRALI)
    Sachs, U. J.
    ONKOLOGIE, 2012, 35 : 248 - 248
  • [3] Diagnosis of transfusion-related acute lung injury (TRALI): TRALI or not TRALI?
    不详
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2005, 35 (02): : 218 - 218
  • [4] Transfusion-related acute lung injury (TRALI)
    Rouger, P
    VOX SANGUINIS, 2001, 81 (04) : 276 - 277
  • [5] Diagnosis of transfusion-related acute lung injury: TRALI or not TRALI?
    Fontaine, MJ
    Malone, J
    Mullins, FM
    Grumet, FC
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2006, 36 (01): : 53 - 58
  • [6] Investigating transfusion-related acute lung injury (TRALI)
    Fung, YL
    Goodison, KA
    Wong, JKL
    Minchinton, RM
    INTERNAL MEDICINE JOURNAL, 2003, 33 (07) : 286 - 290
  • [7] The pathogenesis of transfusion-related acute lung injury (TRALI)
    Bux, Jurgen
    Sachs, Ulrich J. H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 136 (06) : 788 - 799
  • [8] Transfusion-related acute lung injury (TRALI)—an important, severe transfusion-related complication
    Marco Bueter
    Andreas Thalheimer
    Frank Schuster
    Markus Böck
    Christina von Erffa
    Detlef Meyer
    Martin Fein
    Langenbeck's Archives of Surgery, 2006, 391 : 489 - 494
  • [9] Transfusion-related acute lung injury (TRALI) -: an important, severe transfusion-related complication
    Bueter, Marco
    Thalheimer, Andreas
    Schuster, Frank
    Boeck, Markus
    von Erffa, Christina
    Meyer, Detlef
    Fein, Martin
    LANGENBECKS ARCHIVES OF SURGERY, 2006, 391 (05) : 489 - 494
  • [10] The immunological conflict in the transfusion-related acute lung injury or TRALI
    Drouet, C.
    Khoy, K.
    Masson, D.
    Bardy, B.
    Giannoli, C.
    Dubois, V.
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2011, 18 (02) : 224 - 229